Turning Point Therapeutics, Inc. Operating Cash Flow
Turning Point Therapeutics, Inc. reported Operating Cash Flow of -$163.63 million for the 6-month period ending 2022-06-30, per its 10-Q filed 2022-08-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2022-08-08
- Turning Point Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2022-06-30 was -$105.30M.
- Turning Point Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2022-03-31 was -$58.33M.
- Turning Point Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2021-12-31 was -$54.15M.
- Turning Point Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2021-09-30 was -$41.66M, a 2395.59% decline year-over-year.
- Turning Point Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2021 was -$153.88M.
- Turning Point Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2020 was -$82.79M.
- Turning Point Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2019 was -$57.68M.
- Turning Point Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2018 was -$23.53M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2022-06-30 | -$105.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$163.63M 10-Q · filed 2022-08-08 | -$217.78M derived: sum of 3 quarters · filed 2022-08-08 | -$259.44M derived: sum of 4 quarters · filed 2022-08-08 | |||
| 2022-03-31 | -$58.33M 10-Q · filed 2022-05-10 | -$112.48M derived: sum of 2 quarters · filed 2022-05-10 | -$154.15M derived: sum of 3 quarters · filed 2022-05-10 | -$196.57M derived: sum of 4 quarters · filed 2022-08-08 | |||
| 2021-12-31 | -$54.15M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$95.82M derived: sum of 2 quarters · filed 2022-02-28 | -$138.24M derived: sum of 3 quarters · filed 2022-08-08 | -$153.88M 10-K · filed 2022-02-28 | |||
| 2021-09-30 | -$41.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$84.09M derived: sum of 2 quarters · filed 2022-08-08 | -$99.73M 10-Q · filed 2021-11-09 | -$133.18M derived: sum of 4 quarters · filed 2022-08-08 | |||
| 2021-06-30 | -$42.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$58.07M 10-Q · filed 2022-08-08 | -$91.52M derived: sum of 3 quarters · filed 2022-08-08 | -$89.70M derived: sum of 4 quarters · filed 2022-08-08 | |||
| 2021-03-31 | -$15.65M 10-Q · filed 2022-05-10 | -$15.68M 10-Q · filed 2021-05-05 | -$49.09M derived: sum of 2 quarters · filed 2022-05-10 | -$47.28M derived: sum of 3 quarters · filed 2022-05-10 | -$70.58M derived: sum of 4 quarters · filed 2022-05-10 | ||
| 2020-12-31 | -$33.45M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$31.63M derived: sum of 2 quarters · filed 2022-02-28 | -$54.93M derived: sum of 3 quarters · filed 2022-02-28 | -$82.79M 10-K · filed 2022-02-28 | |||
| 2020-09-30 | $1.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$21.48M derived: sum of 2 quarters · filed 2021-11-09 | -$49.35M 10-Q · filed 2021-11-09 | -$49.42M 10-Q · filed 2020-11-12 | -$63.35M derived: sum of 4 quarters · filed 2022-02-28 | ||
| 2020-06-30 | -$23.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$51.16M 10-Q · filed 2021-08-09 | -$65.16M derived: sum of 3 quarters · filed 2022-02-28 | -$81.71M derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2020-03-31 | -$27.87M 10-Q · filed 2021-05-05 | -$41.87M derived: sum of 2 quarters · filed 2022-02-28 | -$58.41M derived: sum of 3 quarters · filed 2022-02-28 | -$75.36M derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2019-12-31 | -$14.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$30.55M derived: sum of 2 quarters · filed 2022-02-28 | -$47.50M derived: sum of 3 quarters · filed 2022-02-28 | -$57.68M 10-K · filed 2022-02-28 | -$57.76M 10-K · filed 2020-03-18 | ||
| 2019-09-30 | -$16.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$33.50M derived: sum of 2 quarters · filed 2020-11-12 | -$43.69M 10-Q · filed 2020-11-12 | -$51.54M derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2019-06-30 | -$16.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$27.14M 10-Q · filed 2020-08-10 | -$35.00M derived: sum of 3 quarters · filed 2021-03-01 | -$40.12M derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2019-03-31 | -$10.19M 10-Q · filed 2020-05-12 | -$18.05M derived: sum of 2 quarters · filed 2021-03-01 | -$23.17M derived: sum of 3 quarters · filed 2021-03-01 | -$28.33M derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2018-12-31 | -$7.86M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$12.98M derived: sum of 2 quarters · filed 2021-03-01 | -$18.14M derived: sum of 3 quarters · filed 2021-03-01 | -$23.53M 10-K · filed 2021-03-01 | |||
| 2018-09-30 | -$5.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | -$10.28M derived: sum of 2 quarters · filed 2019-11-04 | -$15.68M 10-Q · filed 2019-11-04 | ||||
| 2018-06-30 | -$5.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$10.55M 10-Q · filed 2019-08-06 | |||||
| 2018-03-31 | -$5.39M 10-Q · filed 2019-05-31 | ||||||
| 2017-12-31 | -$12.64M 10-K · filed 2020-03-18 |